FGP
MPT

Freestone Grove Partners’s Medical Properties Trust MPT Stock Holding History

Freestone Grove Partners’s Portfolio MPT Stock Details MPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.2K Buy
+6,519
New +$34K ﹤0.01% 853

Other funds holding MPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WAM
Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

Freestone Grove Partners's MPT Position: Q1 2026 in Review

Freestone Grove Partners opened a new position in Medical Properties Trust (MPT) in Q1 2026: 6,519 shares worth $30.2K. The stake represents ﹤0.01% of the portfolio and ranks #853 among its holdings.

491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • Freestone Grove Partners held 6,519 shares of Medical Properties Trust worth $30.2K as of Q1 2026.
  • Medical Properties Trust was a new Freestone Grove Partners position in Q1 2026.
  • Medical Properties Trust made up ﹤0.01% of Freestone Grove Partners's portfolio in Q1 2026, its #853 holding.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.